Eargo (NASDAQ:EAR) reported quarterly losses of $(0.82) per share. This is a 127.78 percent decrease over losses of $(0.36) per share from the same period last year.
Microcap Biotech Stock RenovoRx is Shooting Higher Today: Here’s Why
RenovoRx Inc (NASDAQ: RNXT) presented new data on progression-free survival (PFS) from the pivotal Phase 3 open-label TIGeR-PaC study of RenovoGem (intra-arterial administration of gemcitabine) in locally